Position in ATNM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$75,475
+$17,526 QoQ
Shares Held
75,855
+78.0% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. ATNM ranks #372 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ATNM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $75,475 | 75,855 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $57,949 | 42,610 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $57,432 | 35,895 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $83,987 | 59,991 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $367,517 | 228,272 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $317,431 | 251,930 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $451,421 | 240,118 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,690,596 | 228,459 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,805,636 | 230,605 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,150,070 | 226,392 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,304,672 | 220,384 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,627,472 | 219,336 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $421,091 | 44,560 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $476,949 | 44,784 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $289,538 | 39,233 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $183,039 | 38,054 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $190,960 | 37,370 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $228,295 | 37,986 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $339,594 | 38,329 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $300,991 | 38,052 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $206,517 | 27,102 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $213,096 | 27,320 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $261,087 | 26,944 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||